• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension.

作者信息

Olsson Karen M, Hoeper Marius M

机构信息

Dept of Respiratory Medicine, Hannover Medical School and German Center of Lung Research (DZL), Hannover, Germany.

出版信息

Eur Respir J. 2018 Oct 18;52(4). doi: 10.1183/13993003.01745-2018. Print 2018 Oct.

DOI:10.1183/13993003.01745-2018
PMID:30337490
Abstract
摘要

相似文献

1
Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension.系统性硬化症和肺动脉高压患者的风险评估
Eur Respir J. 2018 Oct 18;52(4). doi: 10.1183/13993003.01745-2018. Print 2018 Oct.
2
Identifying early pulmonary arterial hypertension in patients with systemic sclerosis.识别系统性硬化症患者中的早期肺动脉高压。
Eur Respir J. 2018 Apr 4;51(4). doi: 10.1183/13993003.00495-2018. Print 2018 Apr.
3
Pulmonary arterial hypertension: screening challenges in systemic sclerosis and future directions.肺动脉高压：系统性硬化症的筛查挑战及未来方向
Eur Respir J. 2017 May 11;49(5). doi: 10.1183/13993003.00522-2017. Print 2017 May.
4
Independence Day: Separating Right Ventricular Function From Pulmonary Arterial Hypertension in Systemic Sclerosis.独立日：在系统性硬化症中将右心室功能与肺动脉高压区分开来
Circulation. 2016 Jun 14;133(24):2345-7. doi: 10.1161/CIRCULATIONAHA.116.023237. Epub 2016 May 11.
5
Right ventricular longitudinal strain is diminished in systemic sclerosis compared with idiopathic pulmonary arterial hypertension.与特发性肺动脉高压相比，系统性硬化症患者的右心室纵向应变降低。
Eur Respir J. 2017 Nov 22;50(5). doi: 10.1183/13993003.01436-2017. Print 2017 Nov.
6
Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.特发性肺动脉高压和系统性硬皮病相关肺动脉高压患者的甲襞毛细血管变化。
Microvasc Res. 2017 Nov;114:46-51. doi: 10.1016/j.mvr.2017.06.005. Epub 2017 Jun 12.
7
Does left heart disease cause most systemic sclerosis associated pulmonary hypertension?大多数系统性硬化症相关的肺动脉高压是由左心疾病引起的吗？
Eur Respir J. 2013 Oct;42(4):888-90. doi: 10.1183/09031936.00025413.
8
Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.系统性硬化症相关肺动脉高压与特发性肺动脉高压治疗中右心室功能变化的差异。
Ann Am Thorac Soc. 2017 May;14(5):682-689. doi: 10.1513/AnnalsATS.201608-655OC.
9
Biomarkers in systemic sclerosis-related pulmonary arterial hypertension.系统性硬皮病相关肺动脉高压的生物标志物。
Curr Vasc Pharmacol. 2011 Mar;9(2):213-9. doi: 10.2174/157016111794519381.
10
Systemic sclerosis complicated by arrhythmogenic right ventricular dysplasia that was misinterpreted as pulmonary arterial hypertension.系统性硬化症并发致心律失常性右室心肌病，被误诊为肺动脉高压。
Mod Rheumatol. 2012 Feb;22(1):152-7. doi: 10.1007/s10165-011-0484-x. Epub 2011 Jun 25.

引用本文的文献

1
Cross-cultural validation of the Chinese version of the EmPHasis-10 questionnaire in connective tissue disease patients with pulmonary arterial hypertension and its relationship with risk stratification.中文版本的 EmPHasis-10 问卷在结缔组织病合并肺动脉高压患者中的跨文化验证及其与风险分层的关系。
BMC Pulm Med. 2022 Jul 5;22(1):264. doi: 10.1186/s12890-022-02056-1.
2
Regular Risk Assessment in Pulmonary Arterial Hypertension - A Whistleblower for Hidden Disease Progression.肺动脉高压的定期风险评估——隐匿性疾病进展的警示信号
Acta Cardiol Sin. 2022 Mar;38(2):113-123. doi: 10.6515/ACS.202203_38(2).20211005A.
3
The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis.
肺动脉高压靶向治疗在系统性硬化症中的作用
F1000Res. 2019 Dec 19;8. doi: 10.12688/f1000research.20313.1. eCollection 2019.